Message
AKBM: MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER
February 21, 2025 – Trond Atle Smedsrud, CEO Emerging Business, Aker BioMarine, purchased 6000 shares in Aker BioMarine ASA at an average price of NOK 66 per share on February 21 through his wholly-owned investment company Hawi Holding AS. The shares were acquired on Oslo Børs. Following the transaction, Smedsrud holds a total of 10 410 shares in Aker BioMarine ASA.
For further information, please contact
Christopher Robin Vinter, VP Strategic Finance & IR
Mobile: +47 911 60 820
Email: Christopher.vinter@akerbiomarine.com
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.
About Aker BioMarine:
Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION (reduce and recycle plastic waste across industries) and Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.
Message ID 639480